智通财经APP获悉，Sage Therapeutics ...

In recent trading, Lightwave Logic Inc (LWLG) stock price has shown some volatility, fluctuating 8.55% over the last five trades and 11.88% over the past 30 trades. This represents a notable shift ...

科罗拉多州英格尔伍德 - 专门从事杂项塑料产品的Lightwave Logic, Inc. (NASDAQ:LWLG)公司报告称,其独立注册会计师事务所发生了变更。周一,Morison Cogen LLP辞去了其职务,公司审计委员会已任命Stephano Slack LLC为新的认证会计师。 Morison的辞职于2024年9月30日生效,这并非由于对2023年和2022财年财务报表的任何不利意见 ...

Imagine a future where indoor wireless communication systems handle skyrocketing data demands and do so with unmatched ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

周二，Oppenheimer调整了对Sage Therapeutics (NASDAQ:SAGE)的展望，将目标价从之前的10美元下调至9美元，同时维持对该股的"表现"评级。这一调整是在Sage宣布其药物dalzanemdor未能在评估阿尔茨海默病相关轻度认知障碍（AD-MCI）患者治疗的2期LIGHTWAVE研究中达到主要目标之后做出的。 LIGHTWAVE研究的结果被视为一个挫折，尽管在该药物 ...

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

Shares of Sage Therapeutics, Inc. SAGE were down 4.3% on Oct. 8 after the company announced disappointing top-line data from ...

Sage Therapeutics is a sell due to failure of SAGE-324 in essential tremors and dalzanemdor's poor performance in Parkinson's ...

智通财经APP获悉，Sage Therapeutics (SAGE.US) 周二宣布阿尔茨海默病治疗药物dalzanemdor ...

Lightwave Logic, Inc. (NASDAQ: LWLG), a technology platform company leveraging its proprietary electro-optic (EO) polymers to ...

ICC讯 光互联网论坛（OIF）是推动光学互操作性的核心力量。它领导了多个项目，以促进各种光网络和以太网服务配置的互操作性。在2024年的ECOC贸易展上，OIF组织了一场互操作性演示，展现了34家成员公司之间的实时协作。